Drugs & Diseases

Recent Drug Updates

  • teplizumab (Tzield) FDA approves CD3-targeted monoclonal antibody to delay onset of stage 3 type 1 diabetes mellitus
  • tremelimumab (Imjudo) New combination with durvalumab and chemotherapy approved for metastatic non-small cell lung cancer
  • brentuximab vedotin (Adcetris) FDA approves use in combination with chemotherapy for previously untreated high-risk cHL in patients aged 2 years and older

Slideshow Collections